Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy

Published:2006 Issue:5 Volume:106 Page:1154-1161
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bacci Gaetano,Longhi Alessandra,Versari Michela,Mercuri Mario,Briccoli Antonio,Picci Piero

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. , . Monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocol based upon HDMTX, associated with systematic conservative surgery. In: editor. Osteosarcoma in adolescent and young adults. Boston: Kluwer Academic, 1993: 124–132.

2. Chemotherapy in osteogenic sarcoma: The experience of the Pediatric Department of the Gustave Roussy Institute

3. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

4. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

5. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Cited by 485 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constructing a Nomogram for Predicting Pelvic Osteosarcoma: A Retrospective Study Based on the SEER Database and a Chinese Cohort;British Journal of Hospital Medicine;2024-08-30

2. The management of osteosarcoma in children and adolescents in a resource-limited setting: quality improvement considerations to improve treatment outcomes;BMC Cancer;2024-08-28

3. Endoprosthetic replacement with preservation of the epiphysis for proximal tibial reconstruction after osteosarcoma resection in children: a case report;BMC Musculoskeletal Disorders;2024-07-20

4. Oral microbiota distinguishes patients with osteosarcoma from healthy controls;Frontiers in Cellular and Infection Microbiology;2024-07-11

5. Japanese orthopaedic association (JOA) clinical practice guideline on the management of primary malignant bone tumors - Secondary publication;Journal of Orthopaedic Science;2024-07